Race disparities in Wilms tumor incidence and biology.

Department of Pediatric Surgery, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Journal of Surgical Research (Impact Factor: 2.02). 03/2011; 170(1):112-9. DOI: 10.1016/j.jss.2011.03.011
Source: PubMed

ABSTRACT Wilms tumor (WT) is thought to arise in children of Black African ancestry with greater frequency than in Whites. To clarify the biological basis for race disparities in WT, we first verified that Black children residing in Tennessee have an increased incidence of WT, and second, established molecular profiles in WT that are specific to race.
To assess race disparities in WT epidemiology, the Tennessee Cancer Registry (TCR) was queried for all in-state patients less than 20 y of age and registered between 1999 and 2008. To explore race disparities in WT biology, six Black and four White WT specimens acquired in Tennessee were analyzed using imaging mass spectrometry (IMS).
TCR data show that Black children are over-represented among WT patients (29%) relative to all other childhood cancers (18.5%; P = 0.01). WT ranked the fifth most common cancer diagnosis among Blacks, but ninth among Whites. The diagnosis of WT occurred 79% more frequently among Blacks (n = 28) than Whites (n = 69; P = 0.01), and proportionally more Blacks tended to present with distant disease. Although overall survival from WT was not statistically different between Blacks (92.9%) and Whites (94.0%), Black males showed the lowest survival (85%; P = 0.21). IMS analysis identified peptide spectra from both WT blastema and stroma that independently classify specimens according to race with greater than 80% accuracy.
In Tennessee, Black children appear more susceptible than Whites to develop WT. Race-specific molecular profiles can be determined that may help to clarify pathways of Wilms tumorigenesis and the biological basis for race disparities in WT incidence and biology.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Survival from Wilms Tumor (WT) exceeds 90% at 5years in developed nations, whereas at last report, 2-year event-free survival (EFS) in Kenya reached only 35%. To clarify factors linked to these poor outcomes in Kenya, we established a comprehensive web-based WT registry, comprised of patients from the four primary hospitals treating childhood cancers. WT patients diagnosed between January 2008 and January 2012 were identified. Files were abstracted for demographic characteristics, treatment regimens, and enrollment in the Kenyan National Hospital Insurance Fund (NHIF). Children under 15years of age having both a primary kidney tumor on imaging and concordant histology consistent with WT were included. Two-year event-free survival (EFS) was 52.7% for all patients (n=133), although loss to follow up (LTFU) was 50%. For the 33 patients who completed all scheduled standard therapy, 2-year EFS was 94%. Patients enrolled in NHIF tended to complete more standard therapy and had a lower hazard of death (Cox 0.192, p < 0.001). Survival of Kenyan WT patients has increased slightly since last report. Notably, WT patients completing all phases of standard therapy experienced 2-year survival approaching the benchmarks of developed nations. Efforts in Kenya should be made to enhance compliance with WT treatment through NHIF enrollment.
    Journal of Pediatric Surgery 06/2013; 48(6):1254-1262. · 1.38 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Matrix-assisted laser desorption ionization (MALDI)-profiling and imaging mass spectrometry are promising technologies for measuring hundreds of different molecules directly on tissues. For instance, small molecules, drugs and their metabolites, endogenous lipids, carbohydrates and complex peptides/proteins can be measured at the same time without significant disruption of sample integrity. In this review, the potential of MALDI-profiling/imaging technologies in disease proteomics, drug action and studies of cellular processes in the context of kidney tissue is described. Spatial and sequence information obtained in tissue MALDI-profiling/imaging studies can be correlated with other mass spectrometry-based techniques, auxiliary imaging technologies and routine (immuno) histochemical staining.
    Nephrology Dialysis Transplantation 04/2013; · 3.37 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Wilms tumor (WT) is the most common renal malignancy of childhood. Our aim was to verify the epidemiological profile and prognosis of a sample of patients from Brazil and compare them to similar data especially presented in studies developed in Latin America. The sample consisted of consecutive patients diagnosed with WT in an onco-hematology service of a referral hospital in Southern Brazil, in the period between 1989 and 2009. Clinical, radiological, pathological and survival data were collected from the medical records. The analysis was performed using Excel program and SPSS version 18.0. The significance level was of P<0.05. Our final sample consisted of 45 patients. The male/female ratio was 1.25:1. The mean age at diagnosis was 43.9 months and all patients were Euro-descendants. Thirty three patients (73.3%) presented both signs/symptoms of abdominal mass and hypertension. Malformations were observed in 9 patients (20%). There was a case of Fanconi's anemia (2.2%). Three cases were bilateral (6.7%). The majority of patients had stage III and IV (62.2%). We found that patients with malformations had an earlier age at diagnosis (P= 0.018) and more bilateral disease (P= 0.044). The overall survival was 75%. Age at diagnosis was the only significant independent predictor associated to death. We believe that our deaths are closely related to late diagnosis. Oncologic services should also be concerned about the morbidities caused by therapeutical options in these late diagnosed cases and its consequences in the quality of life of the patients.
    Pediatrics International 01/2014; · 0.88 Impact Factor


Available from